scholarly journals Novel corona Virus (2019-nCoV) - An Ancient Ayurveda Epidemiology Literature Review.

2020 ◽  
Vol 8 (02) ◽  
Author(s):  
GANGAPRASAD ANANTRAO WAGHMARE
Keyword(s):  
Mortality Rate ◽  
Severe Acute Respiratory Syndrome ◽  
World Health Organization ◽  
Communicable Disease ◽  
World Health ◽  
Rate Estimate ◽  
Corona Virus ◽  
The World ◽  
Health Organization ◽  
Epidemic Diseases

 Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death   Initially, the World Health Organization (WHO) had mentioned 2% as a mortality rate estimate in a press conference on Wednesday, January 29 and again on February 10. However, on January 29 2020 WHO specified that this was a very early and provisional estimate that might have changed. 3.4% Mortality Rate estimate by the World Health Organization (WHO) as of March 3 2020.                           The concept of epidemic was very much well defined in Ayurveda, Acharya Charaka the great physician of all ages had mentioned the epidemic diseases under the heading of “Janapadodhwans”.The aim of this review study is to understand the ancient Ayurveda epidemic literature , to prevent people from getting affected by epidemic diseases and to enlighten on epidemic diseases prevention & Management through Ayurveda. Keywords: Novel corona Virus (2019-nCoV),severe acute respiratory syndrome,Janapadodhwans,Ayurveda,epidemic Diseases,communicable disease,Panchakarma, Rasayan .  

scholarly journals COVID-19: an Indian perspective

2020 ◽  
Vol 7 (5) ◽  
pp. 2003
Author(s):  
Prahlad Kadambi
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
World Health Organization ◽  
Index Case ◽  
World Health ◽  
Corona Virus ◽  
First Case ◽  
The World ◽  
Health Organization ◽  
The University ◽  
Indian Perspective

Severe acute respiratory syndrome coronavirus 2 is currently spreading globally rapidly. The World Health Organization (WHO) named the virus as the 2019 novel corona virus (2019-nCoV) on January 7, 2020. On February 11th 2020, the illness associated was named as 2019 coronavirus disease (COVID-19). Subsequently, the WHO declared COVID-19 as a pandemic on 11 March 2020. The first case of COVID-19 was reported in India on 30 January 2020 in Thrissur, Kerala. This was the index case in India who tested positive after coming for a vacation. This individual was a student of the University of Wuhan. Subsequent cases were reported in Kerala. Subsequently, the number of cases in India increased to 519 as on 24th March 2020 with mortality in 7 patients as on 22nd March 2020 and 10 patients on 24th March 2020.

scholarly journals Physical Activity during the Pandemic

2020 ◽  
Vol 2 (1) ◽  
pp. 14-29
Author(s):  
Afriwardi
Keyword(s):  
Physical Activity ◽  
Mortality Rate ◽  
World Health Organization ◽  
Virus Disease ◽  
The Elderly ◽  
World Health ◽  
Life Data ◽  
Corona Virus ◽  
The World ◽  
Health Organization

The spread of Corona virus disease 19 (Covid-19) which has been going on since December 2019 has had a very broad impact on all walks of life. Data quoted from the official website of the World Health Organization (WHO), as of September 25, 2020, reported that there were more than 31,026,758 confirmed cases of Covid-19 worldwide, and more than 755,786 people had died with positive Covid-19 ( 1). Meanwhile in Indonesia, as monitored by the Kompas.com website, 137,468 confirmed cases of Covid-19 were reported and more than 6,071 people died. The mortality rate is estimated to be 4.416%, of which most cases involve the elderly (> 80%) (2). Seeing the reality on the ground, by not being disciplined in responding to health protocols to prevent Covid-19 transmission, this number will continue to show an increase.

scholarly journals Average Mortality Rate of COVID-19 in Iran

2020 ◽  
Author(s):  
Sajjad Baber
Keyword(s):  
Mortality Rate ◽  
World Health Organization ◽  
Virus Disease ◽  
Hubei Province ◽  
World Health ◽  
Wuhan City ◽  
Corona Virus ◽  
The World ◽  
Health Organization

Background: Corona virus disease was first reported in Wuhan City, Hubei province, China. Soon the corona virus disease has spread to many countries. World health organization has described the situation as Pandemic. By 12 March 2020, corona virus disease has affected 125 countries around the world. Corona virus was first confirmed in Iran on 19 February 2020. Objective: The aim of writing this small article is to determine the mortality rate of corona virus disease in different cities of Iran. This article will give readers an idea of different ways to control spread of corona virus disease in Iran. Methods: Author has collected the data of daily confirmed cases from different diagnostic centers and hospitals across the country from 19 February 2020 to 1 April 2020. Results: Mortality rate of corona virus disease is roughly 4%. Conclusions: Mortality rate could rise if COVID 19 infection is not controlled.

scholarly journals DETAILED INFORMATION ON FAVIPIRAVIR: DRUG FOR TREATMENT OF SARS-COV-2

2020 ◽  
pp. 13-17
Author(s):  
MONAJI SANJANA REDDY
Keyword(s):  
Clinical Trials ◽  
Side Effects ◽  
Severe Acute Respiratory Syndrome ◽  
World Health Organization ◽  
Respiratory Illness ◽  
World Health ◽  
Genetic Mutations ◽  
Corona Virus ◽  
The World ◽  
Health Organization

Severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) is another name given to pandemic disease COVID-19 that is caused by a newly discovered coronavirus. People infected with coronavirus will experience mild-to-moderate respiratory illness, and it can be seen in a serious stage when comorbidities include along with it. This is now creating a huge pandemic situation all over the world with a huge rate of sufferers, that is, around 9.06 million around the world and about 440 k in India till today according to the World Health Organization. This is a serious condition that should be solved with vaccine only as coronavirus is undergoing mutation it makes difficult to invent a vaccine for it. So far, about 200 genetic mutations have been discovered across the world also in these 198 mutations appeared independently more than once. Due to this pandemic situation, there are so many clinical trials going on in discovering vaccines. Recently, after many trails conducting favipiravir are found to be the most successful in treating any stage of SARS-CoV-2. This article focuses completely on this area, along with its mechanism, side effects, uses, and contraindications.

scholarly journals SARS-CoV-2-Cholesterol Interaction: A Lot of Food for Thought

Pathogens ◽  
2021 ◽  
Vol 10 (1) ◽  
pp. 32
Author(s):  
Giovanni Di Guardo
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
World Health Organization ◽  
World Health ◽  
The World ◽  
Global Catastrophe ◽  
Health Organization

With over 80 million cases, and 1,800,000 deaths reported at the end of 2020 by the World Health Organization, the “CoronaVirus Disease-2019” (CoViD-19) pandemic, caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), should be viewed as a global catastrophe [...]

Impact OF Covid-19 on Several Industries in Context with the Dialysis Industry

2021 ◽  
Vol 8 (2) ◽  
pp. 01-03
Author(s):  
Ashish Gujrathi
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
World Health Organization ◽  
World Health ◽  
Healthcare Sector ◽  
Growth Opportunities ◽  
Wuhan City ◽  
First Case ◽  
The World ◽  
New Challenges ◽  
Health Organization

Coronavirus (COVID-19) was recognized in late December in Hubei province of Wuhan city in China. This highly contagious disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from humans to humans. After the first case in Wuhan, the disease rapidly spread to other parts of the globe. On March 11, 2020, the World Health Organization (WHO) made an assessment that COVID-19 can be characterized as a pandemic. Thus, social-distancing became an important measure to stop the spread of this disease. Various countries across the world adopted nationwide lockdowns. This led to a completely new scenario for the world, where every business in each industry faced new challenges and witnessed new opportunities. Similarly, the medical personal protective industry, a vital part of the healthcare sector, also witnessed new growth opportunities.

scholarly journals Covid-19 and Acute Kidney Injury: Recent Updates

2021 ◽  
Vol 4 (2) ◽  
Author(s):  
Salman Tahir Shafi
Keyword(s):  
Acute Kidney Injury ◽  
Severe Acute Respiratory Syndrome ◽  
World Health Organization ◽  
Recent Literature ◽  
Kidney Injury ◽  
World Health ◽  
Related Disease ◽  
Increased Risk ◽  
The World ◽  
Health Organization

In January 2020, the pathogen was identified and named by the World Health Organization as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2). The consequent SARS-CoV-2-related disease was defined as coronavirus disease 2019 (COVID-19). As data emerged about characteristics of the disease, it was found to be associated with increased risk of acute kidney injury (AKI). We explore the recent literature and reports emerging from the epicenters of the pandemic to help our viewers understand the nature of AKI among these patients. 

scholarly journals Coronavirus Disease 2019 Occupational Considerations for Surgeons: A Review Article

2021 ◽  
Vol 10 (1) ◽  
pp. 36-41
Author(s):  
Seyed Hesamaddin Banihashemi ◽  
Ahmadreza Karimi ◽  
Hasti Nikourazm ◽  
Behnaz Bahmanyar ◽  
Dariush Hooshyar
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
World Health Organization ◽  
Medical Staff ◽  
Review Article ◽  
World Health ◽  
Published Data ◽  
Rapid Spread ◽  
The World ◽  
Health Organization ◽  
And Control

The severe acute respiratory syndrome coronavirus 2 virus and its associated disease, called coronavirus disease 2019 (COVID-19), first appeared in Wuhan, China in December 2019 and quickly spread around the world. Coronavirus was officially named COVID-19 by the World Health Organization and was recognized as a pandemic due to its rapid spread worldwide. Based on the published data, it is hoped to provide a source for later studies and to help prevent and control the contagious COVID-19 and its characteristics, and considerations that surgeons and medical staff must observe during the epidemic.

scholarly journals Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020

2020 ◽  
Vol 25 (32) ◽  
Author(s):  
Erik Alm ◽  
Eeva K Broberg ◽  
Thomas Connor ◽  
Emma B Hodcroft ◽  
Andrey B Komissarov ◽  
...  
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
World Health Organization ◽  
Data Dissemination ◽  
Sequence Data ◽  
Temporal Distribution ◽  
World Health ◽  
European Region ◽  
The World ◽  
Health Organization ◽  
Over Time

We show the distribution of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genetic clades over time and between countries and outline potential genomic surveillance objectives. We applied three genomic nomenclature systems to all sequence data from the World Health Organization European Region available until 10 July 2020. We highlight the importance of real-time sequencing and data dissemination in a pandemic situation, compare the nomenclatures and lay a foundation for future European genomic surveillance of SARS-CoV-2.

scholarly journals Meningkatnya Risiko Disabilitas Pada Penduduk Dengan Penyakit Tidak Menular: Analisa Lanjut Riskesdas 2013

2019 ◽  
Vol 21 (4) ◽  
Author(s):  
Isfandari Siti ◽  
Betty Roosihermiatie
Keyword(s):  
World Health Organization ◽  
Communicable Disease ◽  
World Health ◽  
Disability Assessment ◽  
Population Groups ◽  
Younger Age ◽  
The World ◽  
People With Disability ◽  
Health Organization ◽  
Develop Program

Intersectoral approach is essential to develop program for people with disability in Indonesia. Coordination across ministries are necessary to manage this issue. The planning, provision and monitoring of medical and support services as well as program for population groups with disability may require assessment. Purpose of this study is to assess disability in Indonesia. Methods: performing analysis of disability data from 2013 Indonesian Household Health Survey known as Riskesdas. Level of disability obtained from two main population groups: those with and without non communicable disease (NCD). They then divided by age. The World Health Organization Disability Assessment Schedule II (WHODASII) was used to measure disability. Results: contribution of NCD on disability is obvious among older age indicated by higher proportion of disability with NCD. While risk of disability among younger age is unclear, since disability with NCDproportion is lower than disability without NCD. Probably risk of disability among younger age is other than NCD. None of the groups had members with extreme disability on their global WHO-DASII scores. The analysis identifi es target groups for each stakeholder to develop program for people with disability to reach their maximum potential. Abstrak Penanganan penduduk dengan disabilitas membutuhkan keterlibatan lintas kementerian. Diperlukan informasi besar masalah penduduk dengan disabilitas di Indonesia. Analisa bertujuan mengetahui besaran masalah. Metode: analisa deskriptif univariat dan bivariat data disabilitas Riskesdas 2013 untuk memperoleh Informasi disabilitas seluruh penduduk. Selanjutnya dilakukan analisa besaran disabilitas pada penduduk dengan dan tanpa Penyakit Tidak Menular (PTM). Kelompok ini kemudian digolongkan menurut umur. Instrumen The World Health Organization Disability Assessment Schedule II (WHO-DASII) digunakan untuk mengukur disabilitas. Hasil: 18% penduduk Indonesia mengalami disabilitas. Informasi lebih rinci 8,2% mengalami kesulitan ringan, 6,8% kesulitan sedang dan 3% kesulitan berat. Kontribusi PTM terhadap disabilitas terlihat jelas pada kelompok usia 45 tahun atau lebih ditunjukkan dengan lebih tingginya proporsi disabilitas dengan PTM. Sedangkan risiko disabilitas pada kelompok usia sebelum 45 tahun bukan PTM, karena proporsidisabilitas dengan PTM lebih rendah.

Sign in / Sign up

Export Citation Format

Share Document